Total Number of Communication Reports: 1
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health
|
Food and Drug Regulations specifically with respect to approval, regulation and life-cycle management of therapeutic products
|
Regulation
|
Health
|
Food and Drug Regulations with respect to Data Protection under. C.08.004
|
Regulation
|
Health
|
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
|
Policies or Program
|
Health
|
Health care system policies or programs with respect to pharmaceuticals
|
Policies or Program
|
Economic Development, Health, Industry, Intellectual Property, Research and Development, Science and Technology
|
Innovation Strategy led by Industry, Science and Economic Development Canada, particularly with respect to the life sciences priority under the Innovation Strategy
|
Policies or Program
|
Intellectual Property
|
Patent Act as it relates to the regulation of intellectual property for therapeutic products
|
Policies or Program
|
Intellectual Property
|
Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations
|
Regulation
|
Intellectual Property
|
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
|
Policies or Program
|
Address:
55 Metcalfe Street - Suite 1220
Ottawa, ON K1P 6L5
Canada
Telephone number:
613-236-0455
Ext.
226
Declan Hamill, Vice President, Legal, Regulatory Affairs & Compliance
Innovative Medicines Canada is not a subsidiary of any other parent companies.
Innovative Medicines Canada is not a coalition.
The activities of Innovative Medicines Canada are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Innovative Medicines Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Stephen Sampson | Public offices held
Firm: Global Public Affairs